IVSI - ETF AI Analysis
Top Page
Applied Finance IVS International Large ETF (IVSI)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive recent momentum.
Leading Growth-Oriented Top Holding
The largest position, ASML Holding, has delivered strong performance, helping drive the fund’s overall returns.
Broad International Diversification
Holdings spread across multiple countries such as Japan, the UK, France, Germany, and others help reduce reliance on any single market.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Small Asset Base
With a relatively low level of assets under management, the ETF may face higher trading spreads and a greater risk of closure than larger funds.
Mixed Performance Among Top Holdings
Some key positions, such as LVMH and British American Tobacco, have shown weaker performance, which can offset gains from stronger holdings.
IVSI vs. SPDR S&P 500 ETF (SPY)
AUM7.87M
RegionDeveloped Markets
Expense Ratio0.65%
Beta0.84
IssuerApplied Finance
Inception DateDec 11, 2025
Dividend Yield0.04%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume858
30 Day Avg. Volume1,096
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.99Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering192
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IVSI Summary
IVSI is the Applied Finance IVS International Large ETF, an actively managed fund that invests in large, established companies outside the U.S., mainly in countries like Japan, the UK, France, and Germany. It doesn’t track a set index, but instead picks stocks based on the manager’s research. The fund holds well-known names such as ASML and Novartis, giving investors broad international exposure and potential long-term growth plus diversification beyond the U.S. market. A key risk is that international stocks can be volatile and are affected by currency swings and global economic conditions, so the value can go up and down.
How much will it cost me?This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with managers doing in-depth research to pick international large-cap stocks rather than just tracking an index.
What would affect this ETF?This ETF could benefit if developed markets outside North America grow steadily, especially if demand stays strong for global health care, financial, and technology leaders like ASML, Roche, and AstraZeneca, and if a weaker U.S. dollar makes international stocks more attractive. On the other hand, it could face challenges from slower economic growth in Europe or Japan, tighter global financial conditions, changing regulations affecting banks and drug makers, or a downturn in commodity and luxury goods demand that would hurt holdings like Rio Tinto and LVMH.
IVSI Top 10 Holdings
IVSI leans heavily on Europe and other developed markets outside North America, with ASML clearly in the driver’s seat as its standout, fast-rising tech name. BHP adds a steady lift from the materials side, while Sweden’s Investor AB has been quietly climbing and supporting returns. On the flip side, telecom giant Deutsche Telekom and pharma heavyweight Roche have been lagging, acting like a bit of a brake on the portfolio, and luxury leader LVMH has shown mixed signals, keeping the fund’s consumer exposure more of a slow burn than a spark.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 6.31% | $494.29K | €633.25B | 151.49% | 76 Outperform | |
| Roche Holding AG | 3.42% | $267.70K | $315.55B | 23.56% | 73 Outperform | |
| BHP Group Ltd | 2.69% | $210.30K | AU$311.95B | 75.44% | 68 Neutral | |
| Novartis AG | 2.33% | $182.35K | CHF215.97B | 26.50% | 80 Outperform | |
| ― | 2.19% | $171.74K | ― | ― | ― | |
| Investor AB | 2.02% | $158.53K | kr1.19T | 43.01% | 77 Outperform | |
| Deutsche Telekom | 2.01% | $157.22K | €127.22B | -14.05% | 67 Neutral | |
| AstraZeneca | 1.97% | $154.21K | $271.40B | 27.54% | 80 Outperform | |
| British American Tobacco | 1.91% | $149.69K | £93.69B | 23.50% | 71 Outperform | |
| Allianz | 1.77% | $138.44K | €151.63B | 19.27% | 67 Neutral |
IVSI Technical Analysis
Positive
―
Price Trends
28.14
Positive
27.65
Positive
Market Momentum
0.19
Negative
61.01
Neutral
54.16
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVSI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.53, equal to the 50-day MA of 28.14, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.19 indicates Negative momentum. The RSI at 61.01 is Neutral, neither overbought nor oversold. The STOCH value of 54.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IVSI.
IVSI Peer Comparison
Comparison Results
Performance Comparison
IVSI
Applied Finance IVS International Large ETF
29.07
3.73
14.72%
QUIZ
Zacks Quality International ETF
―
―
―
JIDE
JPMorgan International Dynamic ETF
―
―
―
TACN
T. Rowe Price Active Core International Equity ETF
―
―
―
PQNT
Pictet AI Enhanced International Equity ETF
―
―
―
IVSX
Applied Finance IVS International SMID ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents